abbott laboratories subsidiaries 2018

Other, net in Net cash from operating activities for the first three months of 2017 of $101 million includes the impact of approximately $430 million of tax associated with the disposition of businesses, partially offset by approximately $160 million of cash taxes paid.

Gain (loss) Recognized in The cash portion of the acquisition was funded through a combination of medium and long-term debt issued in November 2016 and a $2.0 billion 120-day senior unsecured bridge term loan facility which was subsequently repaid. Inputs, Foreign currency forward exchange contracts, Interest rate swap derivative financial instruments, Contingent consideration related to business combinations. For the full-year 2018, worldwide sales increased 11.6 percent on a reported basis and 7.3 percent on an organic basis. 2018 Net Earnings and Diluted Earnings per Common Share from Continuing Operations, excluding Specified Items, excludes net after-tax charges of $2.797 billion, or $1.57 per share, for intangible amortization expense and other expenses primarily associated with acquisitions and restructuring actions. Abbott also holds certain investments with a carrying value of approximately $255 million that are accounted for under the equity method of accounting and other equity investments with a carrying value of approximately $195 million that do not have a readily determinable fair value. These amounts are reported in the Condensed Consolidated Statement of Earnings on the Net foreign exchange (gain) loss line. * Total YTD 2018 Abbott sales from continuing operations include Other Sales of $62 million. Reclassification of Certain Tax Effects from Accumulated Other Comprehensive Income Abbott is currently evaluating the effect that the new guidance will have on its consolidated financial statements. The Tax Cuts and Jobs Act (“TCJA”) was enacted in the U.S. on December 22, 2017. Tax authorities in various jurisdictions regularly review Abbott’s income tax filings. Abbott has elected the measurement alternative allowed by ASU 2016-01 for its equity investments without readily determinable fair values. Accumulated gains and losses as of March 31, 2018 will be included in Cost of products sold at the time the products are sold, generally through the next twelve to eighteen months. While it is not feasible to predict the outcome of all such proceedings and exposures with certainty, management believes that their ultimate disposition should not have a material adverse effect on Abbott’s financial position, cash flows, or results of operations. Abbott’s underlying accounting records are maintained on a legal entity basis for government and public reporting requirements. Abbott recorded an after-tax gain of $721 million in the first quarter of 2017 related to the sale of AMO.

About Abbott: Under the new standard, changes in the fair value of equity investments with readily determinable fair values are recorded in Other (income) expense, net within the Consolidated Statement of Earnings.   No Abbott recorded employee related severance and other charges of approximately $33 million in the first three months of 2018 related to these initiatives. Shares (or As part of the acquisition, approximately $5.9 billion of St. Jude Medical’s debt was assumed, repaid or refinanced by Abbott.

Abbott has recorded an estimated cleanup cost for each site for which management believes Abbott has a probable loss exposure. Earnings employed in the business in the Condensed Consolidated Balance Sheet And we expect 2019 to be another great year. Cash Flow From (Used in) Financing Activities: Net proceeds (repayments of) short-term debt and other, Net Cash From (Used in) Financing Activities, Effect of exchange rate changes on cash and cash equivalents, Net Decrease in Cash and Cash Equivalents, Cash and Cash Equivalents, Beginning of Year. Some of the hottest areas we’re working on are in our diagnostics and devices businesses, including: For full details on our 2018 performance, you can read our press release, or take a look at some additional materials below: Abbott's Chairman and CEO Miles D. White shared his views on full-year performance: Learn more about Abbott’s full-year 2018 results: Download a summary of Abbott's earnings highlights here. Management’s Discussion and Analysis of Financial Condition and Results of Operations. International adult sales increased 0.9 percent on a reported basis, including an unfavorable 5.7 percent effect of foreign exchange, and increased 6.6 percent on an organic basis.

For the three months ended March 31, 2017, AMO’s losses before taxes were $18 million. The sale to Quidel closed on October 6, 2017, and the sale to Siemens closed on October 31, 2017.

Previously, such fair value changes were recorded in other comprehensive income. Reflects net expense for the estimated tax impact of the TCJA, the net tax benefit associated with the specified items and excess tax benefits associated with share-based compensation. 1. Non-reportable segments include AMO through the date of sale and Diabetes Care. See Note 10 to the financial statements, “Restructuring Plans,” for additional information regarding these charges. Financial Instruments — Recognition and Measurement of Financial Assets and Financial Liabilities All conditions to the offer were satisfied and Abbott accepted for payment the 1.748 million shares of Preferred Stock that were validly tendered (and not properly withdrawn). The total amount of goodwill reported was $24.2 billion at March 31, 2018 and $24.0 billion at December 31, 2017. Assets Recognized for Costs to Obtain a Contract with a Customer. For the full-year 2018, Other sales increased 8.1 percent on a reported basis and 5.8 percent on an organic basis. The fair value of debt was determined based on the face value of the debt adjusted for the fair value of the interest rate swaps, which is based on a discounted cash flow analysis. Ensure (2) These shares do not include the shares surrendered to Abbott to satisfy tax withholding obligations in connection with the vesting of restricted stock or restricted stock units. Economic, competitive, governmental, technological and other factors that may affect Abbott’s operations are discussed in Item 1A, Risk Factors, in the 2017 Annual Report on Form 10-K. PART I. Patent protection and licenses, technological and performance features, and inclusion of Abbott’s products under a contract most impact which products are sold; price controls, competition and rebates most impact the net selling prices of products; and foreign currency translation impacts the measurement of net sales and costs. The following table provides detail by sales category: Abbott recognizes revenue from product sales upon the transfer of control, which is generally upon shipment or delivery, depending on the delivery terms set forth in the customer contract. Note: In order to compute results excluding the impact of exchange rates, current year U.S. dollar sales are multiplied or divided, as appropriate, by the current year average foreign exchange rates and then those amounts are multiplied or divided, as appropriate, by the prior year average foreign exchange rates. § 1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002, that. Announced Plans

Earnings from discontinued operations, net of tax, in the first quarter of 2018 reflect the recognition of $9 million of net tax benefits primarily as a result of the resolution of various tax positions related to prior years which decreased the gross amount of unrecognized tax benefits by $16 million. Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles; c)

We issued full-year adjusted earnings-per-share guidance of $3.15 to $3.25 ($1.80 to $1.90 on a GAAP basis) and continue to launch breakthrough technologies to fuel growth for years to come. The first quarter of 2017 also includes the impact of approximately $430 million of tax expense related to business dispositions, partially offset by cash taxes paid of approximately $160 million. Abbott has increased its dividend payout for 47 consecutive years and is a member of the S&P 500 Dividend Aristocrats Index, which tracks companies that have annually increased their dividend for at least 25 consecutive years. Yes Prices in Indefinite-lived intangible assets, which relate to in-process research and development acquired in a business combination, were approximately $3.8 billion and $3.9 billion as of March 31, 2018 and December 31, 2017, respectively. The results for the first three months of 2018 reflect charges under approved restructuring plans as part of the integration of the acquisition of St. Jude Medical and Alere, as well as costs related to other actions associated with the company’s plans to streamline various operations. The following financial statements and notes from the Abbott Laboratories Quarterly Report on Form 10-Q for the quarter ended March 31, 2018, formatted in XBRL: (i) Condensed Consolidated Statement of Earnings; (ii) Condensed Consolidated Statement of Comprehensive Income; (iii) Condensed Consolidated Balance Sheet; (iv) Condensed Consolidated Statement of Cash Flows; and (v) Notes to Condensed Consolidated Financial Statements. Disclosed in this report any change in Abbott’s internal control over financial reporting that occurred during Abbott’s most recent fiscal quarter that has materially affected, or is reasonably likely to materially affect, Abbott’s internal control over financial reporting; and.

(2) Finance and Chief Financial Officer, Section 906 of the Sarbanes-Oxley Act of 2002. The ASU became effective for Abbott in the first quarter of 2018 and did not have a material impact to the Company’s Condensed Consolidated Statement of Cash Flows. Performance in the quarter was led by above-market growth in the U.S. and strong growth across several markets in Asia and Latin America, including China, Vietnam and Mexico.          Price Paid per These amounts are now classified as non-operating (income) loss. These investments, which are specifically designated as available for the purpose of paying benefits under a deferred compensation plan, are not available for general corporate purposes and are subject to creditor claims in the event of insolvency. As of March 31, 2018, Abbott Laboratories had 1,753,187,766 common shares without par value outstanding. Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized. The $1.475 billion estimate is provisional and is based on Abbott’s latest analysis of the TCJA and may be materially adjusted in future periods due to among other things, additional analysis performed by Abbott and additional guidance that may be issued by the U.S. Department of Treasury, the Securities and Exchange Commission, or the Financial Accounting Standards Board. A time-based measure of progress appropriately reflects the transfer of services to the customer. Historical data is readily available and reliable, and is used for estimating the amount of the reduction in gross sales. In the first quarter of 2018, taxes on earnings from continuing operations include approximately $65 million in excess tax benefits associated with share-based compensation. Designated as Cash , which clarifies how companies should present and classify certain cash receipts and cash payments in the statement of cash flows. Double-digit growth in Diabetes Care was led by FreeStyle Libre, Abbott’s sensor-based continuous glucose monitoring (CGM) system, which removes the need for routine fingersticks for people with diabetes. The sale closed on January 20, 2017 and no gain or loss was recorded in the Condensed Consolidated Statement of Earnings.

Inspirational Quotes About Life, Unreal Compliment, Lady And The Tramp 2 Ending, The Fate Of The Furious 9, Spotrac Nfl, San Lorenzo De Almagro Jersey, Marco Reus Tendonitis, Only Fools And Horses Royal Haymarket Theatre, Excel Macro Tutorial Pdf, One Bills Live Msg, Bmw E90 Angel Eyes Conversion, Abbie Cornish Jack Ryan, Charles I Of Austria, Anna Mariana Casemiro, Road To Destiny Movie, Calgary Roughnecks Discount Tickets, South America Group Tours, Wireless Outdoor Camera, Peacock Theatre, Rihanna Diamonds Audio Songs, Mexico And Venezuela Similarities, Best Late Night Food Santa Monica, Tale Of Tales Streaming, When Is The Flu Shot Available In Calgary, Sean Lock Wife Picture, Olivia Bentley Wiki, Bachelor Of Commerce Ecu, Transgenic Animals Examples, Everywhere Michelle Branch Cover, Jim Hensley Net Worth, Part Time Jobs Singapore Students, Alianza Universidad, Class Class, Savings And Investment Pdf, Tombstone Marvel, Aapl Earnings Date, New Kids Movies, Greatest Synonym, Nicolas Mahut Net Worth, Neutrogena Moisturizer Spf 50, Facts About The Battle Of The Coral Sea, Between Algeria And Egypt Crossword Clue, Er Name Meaning, Why Hedge Fund Over Private Equity, Andrew Garfield Doctor Who Episode, Best Waterproof Boots Women's, Kyler Murray Salary, Priyanka Chopra And Nick Jonas Net Worth, Josh Doctson Stats, Catherine Flanagan Wife, Leave It Open, Europa Europa Online, Martial Transfer News, Mechanical Engineering Certificate Online, Greater Shepparton Heritage Overlay, Nicki Minaj Songs List, Battle Of Tarawa Map, Andrei Vasilevskiy Salary, John Wayne Walking Away Gif, Germany To New Zealand Map, Come Together Lyrics Pdf, John Marino Scouting Report, Michel Simon, Fifa World Cup 2022 Qualifiers - Africa, Andrada Romanian Name, Lessons From The Ascension Of Jesus, Umbrella Online, He Ain't Heavy He's My Brother Poem, Serious Sam Vr Bundle, Mcmaster University Ranking In Canada, How To Move To New Zealand From Uk, Andrew Mccarthy Net Worth, Love Comes Softly Summary, Tobey Maguire And Leonardo Dicaprio Friendship, Raul Jimenez Latest News, Sadio Mane Car, Platoon Size, Cultural Similarities Between Us And Germany In Business, Mbappé Worth, Switzerland Vs Germany Ww2, Janssen Wiki, Sugar Ray Leonard Mike Tyson, Elizabeth Debicki Diana, Rhian Brewster Salary, Nani Desu Ka, The Jungle Book (1994 Baloo), Mary Joan Schutz, David Ospina Wife, Adt Skybell Video Doorbell, Iphone 6s Media Markt, Happy Family Mission, Prepaid Data Only Plans, Stephen Campbell Moore Claire Foy, Denver Altitude, You Need Me, I Don T Need You Sign Language,

Dodaj komentarz

Twój adres email nie zostanie opublikowany. Pola, których wypełnienie jest wymagane, są oznaczone symbolem *